logo

Loading..
Loading..
logo
  • About the company
    About the company
      • Company in brief
      • Company history
      • Strategy and IP
      • Organisation
      • Founders
      • The Board
      • Senior Management
  • About melflufen
    About melflufen
      • About melflufen
      • Mechanism of action
      • About Multiple Myeloma
      • About our research
        • Selected bibliography (in order of publishing)
  • Our clinical studies
    Our clinical studies
      • Investigator-Initiated Trials
      • Summary
      • O-12-M1
      • HORIZON
      • OCEAN
      • ANCHOR
      • BRIDGE
  • Investor Relations
    Investor Relations
      • The share
        • Share capital development
        • Dividend policy
        • Ownership structure
        • Analysts
      • Press releases
      • Presentations
      • Financial reports
      • Calendar
      • Prospectus
      • Share issue June 2019
      • Share issue January 2019
      • Share issue March 2018
  • Media
    Media
      • Press releases
      • Subscribe
      • Image bank
      • Media contact
  • Corporate governance
    Corporate governance
      • Corporate Governance Reports
      • Governance structure
      • General meeting
        • Extraordinary General Meeting 2019
        • General Meetings
      • Nomination committee
        • Nomination Committee 2020
        • Nomination Committees
      • The Board of Directors
        • Board of Directors
        • Work of the Board of Directors
        • Board committees
      • Senior Management
      • Remuneration
      • Auditors
      • Internal control
      • Articles of association
  • Contact
    Contact
      • Office HQ
      • Office US
      • Investor Relations
      • Medical Affairs
      • Clinical Studies
      • Career
Media Image bank

Image bank

Select category
  • Logotype
  • Management
  • The Board
View Jakob Lindberg
View Anders Martin-Löf
View Christian Jacques
View Elisabeth Augustsson
View Eva Nordström
View Fredrik Lehmann
View Nicolaas Klaas Bakker
View Paula Boultbee
  • Media
    • Press releases
    • Subscribe
    • Image bank
    • Media contact
  • Oncopeptides AB
  • Registration number: 556596-6438
  • info@oncopeptides.com
  • About cookies
  • Personal Data

Welcome to Oncopeptides AB’s (publ) website. In order to optimize your use of our website we use cookies. A cookie is a text file stored on your computer. If you want more information about what a cookie is, what the purpose of the cookie is and how you can block or delete cookies, please read the our cookie guidelines “About cookies”. By continuing, you agree to our use of cookies.

Close